What does this research mean for the field?

Anaemia is a major reversible risk factor for cardiomyopathy in uraemic patients, but while maintaining haemoglobin above 11 g/dl is beneficial, the cardiovascular benefits of fully normalizing haemoglobin levels remain uncertain and likely depend on the stage of cardiac disease. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This study examines the impact of anaemia on cardiovascular status and the potential benefits of treating anaemia in uraemic patients.

September 2, 2000Nephrology Dialysis Transplantation

Effects of anaemia on cardiovascular status

View Full Paper

Ask AI

Bookmark

Why the study?

Does the correction of anaemia improve cardiovascular outcomes in uraemic patients?

Population

Uraemic patients with anaemia and varying stages of cardiomyopathy or cardiac failure

Design

Review

Authors

EOEdmond O’RiordanNational Kidney Foundation RFRobert N. FoleyDartmouth–Hitchcock Medical Center

Discussion

Member takes

Implication

Insufficient evidence precludes routine aggressive anaemia correction in uraemia; leaves open stage-specific CV benefits for targeted trials.

Key Points

This study examines the impact of anaemia on cardiovascular status and the potential benefits of treating anaemia in uraemic patients.
Longitudinal data analysis focusing on left ventricular changes in uraemic patients
Comparison of outcomes in patients with varying levels of anaemia and cardiovascular conditions
Review of observational studies and randomized controlled trials related to anaemia treatment in dialysis patients.
Anaemia is linked to increased risks of left ventricular dilatation and systolic dysfunction.
Maintaining haemoglobin levels above 11 g/dl is associated with reduced mortality and hospitalizations.
There is controversy regarding the optimal haemoglobin target for cardiac benefit, especially in late intervention studies.

Structured PICO

Does the correction of anaemia improve cardiovascular outcomes in uraemic patients?

Population

Uraemic patients with anaemia and varying stages of cardiomyopathy or cardiac failure

Intervention

Correction of anaemia / normalizing haemoglobin concentration (target >11 g/dl)

Outcome

Cardiovascular morbidity, mortality, and hospitalization rates

While anaemia is a key risk factor for cardiomyopathy in uraemic patients, conclusive evidence for the cardiovascular benefits of aggressively normalizing haemoglobin remains lacking.

Cite This Study

O’Riordan et al. (2000) studied this question.

synapsesocial.com/papers/6a1bcadfea84844e355ef7d2 https://doi.org/10.1093/oxfordjournals.ndt.a027971

View Full Paper

Ask AI

Bookmark

Implication

Insufficient evidence precludes routine aggressive anaemia correction in uraemia; leaves open stage-specific CV benefits for targeted trials.

Effects of anaemia on cardiovascular status

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Effects of anaemia on cardiovascular status

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider